<DOC>
	<DOCNO>NCT01845038</DOCNO>
	<brief_summary>The purpose study evaluate OTX-TP , sustain release travoprost drug product , place canaliculus eyelid compare timolol drop lower intraocular pressure ( IOP ) patient open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Multi-Arm Feasibility Study Evaluating OTX-TP Compared Timolol Treatment Subjects With Open Angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subject must great equal 18 year age Screening . Subject must document diagnosis ocular hypertension , open angle glaucoma . Subject mean baseline ( Day 7 Day 0 ) Hour 0 ( T0 ) untreated IOP ≥ 24 mm Hg ≤ 34 mm Hg eye , ( T0 + 4h ) ( T0 + 8h ) IOP ≥ 22 mm Hg Baseline Visit 2 . Untreated IOP must ≤ 34 mm Hg eye time point baseline visit . Subject BCVA 0.6 logMAR ( 20/80 Snellen ) good eye measure use ETDRS chart . Presence uncontrolled systemic debilitating disease ( e.g . cardiovascular disease , hypertension , diabetes , cystic fibrosis ) . Punctum size small 0.4mm great equal 1.0mm . Any single IOP either eye time point Screening either Baseline ( Day 7/Day 0 ) Visits &gt; 34 mm Hg .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>